retatrutide obesity clinical trial results 💉 may be redefining treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide Shows 28% Weight Loss

Presented for research literature review only Mustacich D (2001)

However, the USDA reiterated that there is no overarching regulatory standard for the term "GLP-1 Friendly." Other companies, such as French yogurt maker Lactalis with its Ratio Pro Fiber yogurt, and restaurant chains Chipotle and Shake Shack with new protein-heavy menu items, are targeting GLP-1 users without explicitly mentioning the drugs on their packaging or menus

Inform your doctor immediately to reevaluate your treatment plan

Cosmetic weight loss is perhaps the best application of this term, making it a fast track to thinness

Increased energy and quality of life

Supplier-published stability data is the appropriate reference